Daiichi Sankyo

Activities: Packaging Research & Development Pharmaceutical

Trending Articles

  1. Counteracting counterfeits in the pharmaceutical supply chain Sreedhar Patnala, General Manager at Systech, discusses the comprehensive benefits of embracing traceability
  2. Lonza Capsules & Health Ingredients expands capsule manufacturing capacity in India and China New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari (IN) and Suzhou (CN), highlighting the long-term strategic commitment to...
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Industrial data mastery: navigating the 2025 landscape As industrial manufacturers contend with the ever-increasing volume and variety of operational data, the year ahead promises both complexity and opportunity
  4. Novo Holdings completes acquisition of Catalent Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark
  5. ACG expands global footprint with new capsule manufacturing facility in Thailand New capsule manufacturing facility in Rayong, Thailand, is strategically positioned to serve key Asian markets

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

Related Content

Regulatory

AstraZeneca & Daiichi Sankyo's Enhertu bags another approval for gastric cancer applications

The HER2-targeting ADC has received conditional approval owing to the results of the DESTINY-Gastric06 Phase II trial

Therapeutic: datopotamab deruxtecan for breast cancer

Of all the various forms of breast cancer, triple negative is the most aggressive subtype
Research & Development

AstraZeneca and Daiichi Sankyo reveal phase 3 lung cancer study

Results for the TROP2-directed antibody drug conjugate demonstrated statistically significant improvement in progression-free survival vs. standard chemotherapy
Drug Delivery

ProLynx collaborates with Daiichi Sankyo on drug delivery

The collaboration will evaluate the utility of the releasable linker technology in half-life extension of small-molecule drugs after intravitreal injection
Finance

Heptares Therapeutics enters agreement with Daichi Sankyo

The collaboration aims to discover and develop novel, small-molecules for the treatment of pain
Pharmaceutical

Amgen and Daiichi Sankyo to commercialise biosimilars in Japan

The exclusive agreement includes nine biosimilars in late-stage development
Drug Delivery

Nitto Denko enters drug delivery partnership with Daiichi Sankyo

To accelerate the commercialisation of Nitto’s PassPort transdermal drug delivery technology
Subscribe now